A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study) (3ELM)

January 10, 2023 updated by: Rush University Medical Center

A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome

Approximately 24% of the US adult population meet criteria for metabolic syndrome (MetS), diagnosed by a combination of abdominal obesity, elevated blood pressure, high triglyceride and low HDL-cholesterol level, and pre-diabetes. MetS quintuples the risk of diabetes, and doubles the risk of cardiovascular disease (CVD), particularly heart failure. Lifestyle modification is the initial step of treatment, but few studies have demonstrated early and sustained efficacy in remission of MetS. Our preliminary studies of a lifestyle change program for patients with MetS included a 1-year of development of an intervention by an interdisciplinary team of experts in medicine and the behavioral sciences. The investigators then tested the efficacy of the intervention in a treatment-only, proof-of-concept study. The investigators achieved our goal of 50% MetS remission after 2 years, in a sample of 26 patients. This study is the second step of a research program testing an innovative bio-behavioral intervention aimed at remitting MetS through lifestyle intervention, by focusing on eating patterns, daily activity, and stress management. The overarching objective of this research program is to determine the efficacy of the ELM lifestyle intervention to achieve remission of MetS. This purpose of the current study is to prepare for a large, randomized, clinical trial by conducting a smaller clinical trial that examines the acceptability of the ELM intervention (ELM Group) as compared to two other intervention arms (ELM Classes, ELM Individual).

Study Overview

Detailed Description

The 3ELM ("Eat, Love, Move") study recruits 48 patients with MetS, and provides a 6-month intervention that aims to remit MetS by promoting the long-term adoption of healthier behaviors (diet, physical activity, stress reduction). Participants in 3ELM are randomly assigned to one of the study arms ("ELM Groups", "ELM Classes", "ELM Individual"); all of which receive some type of intervention in either group, class, or individual formats. The primary aim of this project is to pilot test the acceptability of each of the study arms and the outcome measures.

The study also includes outcome assessments at 3 time points: at the start of the study, and at 3, and 6 months post baseline. All study participants will receive medical care (including metabolic syndrome care) from their regular medical doctors. Study staff will track participants' use of health care and wellness services during the study after obtaining participant permission to collect this data.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60612
        • Rush University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 72 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women age 18-72 years (children and the elderly need age-specific lifestyle tailoring).
  • Able to walk 2 blocks (the patients should be able to engage in moderate intensity exercise).
  • Have preference for making lifestyle changes to treat MetS.
  • Able to participate in a lifestyle intervention for 6 months.
  • Meet at least 3 Metabolic syndrome criteria: abdominal obesity (waist girth >102♂/88♀ cm), high blood pressure (≥130/85 mm Hg or treatment), triglyceridemia (≥150 mg/dL or fibrate therapy), low HDL-cholesterol (<40♂/50♀ mg/dL or niacin therapy) or fasting glucose ≥100 mg/dL (or pre-diabetes).

Exclusion Criteria:

  • Substance abuse within the past 12 months: alcohol use, current daily smokers (self-report); and illicit drug use.
  • Weight loss, exceeding 10% of initial weight, in the past 6 months or current use of medications for weight loss, bowel resection surgery, bariatric surgery, eating disorder.
  • Other medical or behavioral limitations judged to interfere with study participation or the ability to follow study procedures (eg, scheduled surgery, travel plans or scheduling difficulties that do not permit full participation), limited English language, cognitive impairment, pregnancy, or psychiatric comorbidities (such as severe major depression, or psychotic disorders).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ELM Group
A 6-month group lifestyle intervention, consisting of 12 weekly and 6 bi-weekly 2-hour sessions. The sessions consist of 30-min physical activity, 30-min meal demonstration, and 60-min group behavioral intervention, with a focus on experiential learning in naturalistic setting. Sessions are facilitated by dietitian/personal trainer and behavioral specialist.
ELM participants are trained to portion their meals according to the "Perfect Plate" method, a modified version of the USDA's ChooseMyPlate.gov. The stress management focuses on mindful living, cognitive restructuring; the enhancement of positive emotions. The physical activity component focuses on reduction of sedentary activity (by increasing daily step counts) and moderate-to-vigorous physical activity.
Other Names:
  • ELM Lifestyle Intervention
Other: ELM Classes
A 6-month health education, consisting of 12 weekly and 6 bi-weekly 30-45 min sessions. The sessions consist of didactic classes, with a focus on health education curriculum. Sessions are facilitated by a health educator and medical providers.
ELM classes will be administered through Rush Generations program and focus on health education.
Other Names:
  • Health Education
Active Comparator: ELM Individual
A 6-month intervention, that consists of educational manuals on physical activity, diet and stress reduction and recommended 3 medical visits every 3 months for medical counseling and feedback using 5A (Ask, Advise, Assess, Assist, and Arrange) framework . These Metabolic syndrome care materials and provider documentation will be embedded in electronic medical record system, and will be accessible to medical providers by usual means. This enhanced usual care by participant's usual health care provider focuses on metabolic syndrome and lifestyle modifications to reduce the risk of chronic disease.
ELM Individual arm participants will receive education materials on metabolic syndrome and diet, exercise, stress reduction recommendations. The participants will be recommended to follow these guidelines and discuss/seek support from their health care provider (visits at baseline, 3 and 6 months will be recommended.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
metabolic syndrome remission, defined as <3 of the 5 standard diagnostic criteria.
Time Frame: 6-month change
metabolic syndrome remission will be assessed by measurement of waist girth, blood pressure, fasting serum lipid and glucose levels, and the number of medications to treat blood pressure.
6-month change

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutrition intake
Time Frame: Baseline, and 6 months
Healthy Eating Index (HEI-2010) will be computed using data from 24-h dietary recalls, conducted on nonconsecutive days, including one weekend day, using the Nutrition Data System for Research (NDSR).128 The HEI-2010 is a quantifiable method of assessing the adherence to Dietary Guidelines for Americans.
Baseline, and 6 months
Accelerometry
Time Frame: At baseline and 6 months
Accelerometry (Actigraph) is the gold standard objective method for daily activity data collection. Standard methods for equipment programming and data reduction, supplemented by activity and sleep log will be used to calculate minutes/week of moderate/vigorous activity, sedentary activity, sleep, and accelerometer step counts.
At baseline and 6 months
International Physical Activity Questionnaire (IPAQ)
Time Frame: At baseline and 6 months
Measures engagement in physical activity
At baseline and 6 months
Perceived Stress Scale
Time Frame: At baseline, 3, and 6 months
a 10-item questionnaire that measures stress
At baseline, 3, and 6 months
Weight
Time Frame: At baseline, 3, and 6 months
Weight will be measured using stationary scale per standardized protocol.
At baseline, 3, and 6 months
A1c
Time Frame: At baseline and 6 months
A plasma sample will be collected to measure HbA1c.
At baseline and 6 months
Credibility and expectancies questionnaire (CEQ)
Time Frame: At baseline, 3, and 6 months
A 4-item questionnaire measures participants acceptability ratings - specifically whether they think the treatments are credible and if they think they will help them with their health goals.
At baseline, 3, and 6 months
Vitality Index
Time Frame: At baseline, 3, and 6 months
will be tracked using a 4 item subscale of Medical Outcomes Study (MOS) 36-Item Short Form Health survey that measures perceived energy and fatigue within the last 30 days.
At baseline, 3, and 6 months
Continuous metabolic syndrome score
Time Frame: At baseline, 3, and 6 months
calculated as a sum of z-scores of the individual 5 MetS components using reported methodology from other clinical trials. This MetS research tool has methodological advantage accounting for severity of MetS.
At baseline, 3, and 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medication questionnaire
Time Frame: At baseline, 3, and 6 months
The list of medications with dose and frequency of administration will be collected using a standardized questionnaire.
At baseline, 3, and 6 months
Brief COPE
Time Frame: At baseline, and 6 months
measures coping of stressors
At baseline, and 6 months
Daily Hassles Questionnaire
Time Frame: At baseline, 3, and 6 months
measures primary and secondary appraisal of stressors.
At baseline, 3, and 6 months
Three Factor Eating Questionnaire (TFEQ)
Time Frame: At baseline, and 6 months
Measures disordered eating patterns.
At baseline, and 6 months
Patient Health Questionnaire (PHQ-9)
Time Frame: At baseline, 3, and 6 months
Measures depressive symptoms
At baseline, 3, and 6 months
Treatment Self-Regulation Questionnaire (TSRQ for eating and physical activity)
Time Frame: At baseline, 3, and 6 months
Measures self-regulation abilities for eating and physical activity
At baseline, 3, and 6 months
Work Productivity and Activity Impairment Questionnaire
Time Frame: At baseline, 3, and 6 months
measures lost productivity in the form of absenteeism and presenteeism.
At baseline, 3, and 6 months
Use of wellness, health, and preventive services
Time Frame: At baseline, 3, and 6 months
Wil be used for cost analysis.
At baseline, 3, and 6 months
Perceived environment (food and exercise)
Time Frame: At baseline
measures the built and food environment
At baseline
Global health scale
Time Frame: At baseline, 3, and 6 months
Self-assessment of overall health.
At baseline, 3, and 6 months
General Questionnaire
Time Frame: At baseline, updated at 3, and 6 months
Measures basic sociodemographic characteristics.
At baseline, updated at 3, and 6 months
Weight history and experiences with wellness/weight management programs
Time Frame: At baseline, and updated at 3 and 6 months
Captures weight fluctuations and participation in commercial or health care based wellness or weight loss programs
At baseline, and updated at 3 and 6 months
Treatment modality preferences and willingness
Time Frame: At baseline and 6 months
Captures participant preferences for lifestyle, medication, and surgical treatment modalities.
At baseline and 6 months
Beliefs about medications
Time Frame: At baseline
Captures participant's beliefs about the usefulness and safety of medications.
At baseline
Time horizon
Time Frame: At baseline and 6 months
Assesses executive function
At baseline and 6 months
Patient Reported Outcomes Measurement Information System (PROMIS) Cognition questionnaire
Time Frame: At baseline and 6 months
measures cognitive/executive function.
At baseline and 6 months
Perceived lifestyle change for physical activity and diet
Time Frame: At 3 and 6 months
Captures participant's self-assessment of effort-related to lifestyle changes.
At 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rasa Kazlauskaite, MD, Rush University Medical Center
  • Study Director: Lisa Walt, PhD, Rush University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2013

Primary Completion (Actual)

August 31, 2015

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

August 29, 2014

First Submitted That Met QC Criteria

September 5, 2014

First Posted (Estimate)

September 8, 2014

Study Record Updates

Last Update Posted (Actual)

January 12, 2023

Last Update Submitted That Met QC Criteria

January 10, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Study Data/Documents

  1. Clinical Study Report
    Information identifier: PMC6589338
    Information comments: A manuscript summarizing the development of the intervention.
  2. Informed Consent Form
    Information identifier: 11111701-IRB01
    Information comments: The informed consent is available through RuMC IRB portal.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on ELM Group

Subscribe